The price already pays for a 23% return held in place

Rs 1,309 is a price that only closes if growth runs close to the discount rate. The desk's reverse calculation, at a 12% cost of equity — an assumption, not a market reading — puts the required long-run growth at 10.65%.

What the price assumes

The mechanics are simple enough to state. Justified price-to-book equals (ROE − g) / (r − g), and the desk solves it for g: the steady growth rate the current price requires, given a return on equity and a cost of equity. At the 12% middle scenario the price implies 10.65% long-run growth on the latest ROE of 23.13%, and 10.69% on the five-year median ROE of 22.83%. The two return inputs barely separate, which is itself informative: the answer is not sensitive to which ROE you pick.

The price carries 9.26 times book and 40 times earnings, an earnings yield of 2.5%. The 40x is not the striking part; the 9.26x book is, because book value per share is Rs 141.43 against a close of Rs 1,309. What that multiple encodes is a return on equity held far above the sector's 5.04% median, plus a growth rate close to the cost of equity, sustained.

Order flow over the last ten sessions has not been one-sided. Buyers paid up in two of them and sellers hit bids in five, with three two-way; median buy-initiated volume was 38.8%. The latest session leaned the other way at 60.7% buy-initiated and steady into the close. Turnover averaged Rs 14.79 crore across the last twenty sessions against Rs 2.62 crore across the prior sixty, a 464.6% step-up, and the shares sit 8.72% higher over twenty sessions, 13.29% over 250 and 3.98% below the 52-week high of Rs 1,363.2. The activity that built this price is recent.

The record it rests on

The five-year record is not a smooth compounding story. FY 2078/79 earned Rs 1.06 arba, an EPS of Rs 69.5 and a return on equity of 37.12%. Then two hard years: FY 2079/80 net profit fell 37.4% to Rs 66.01 crore, EPS Rs 27.17, ROE 19.69%; FY 2080/81 fell another 46.5% to Rs 35.31 crore, EPS Rs 13.21, ROE 10.56%. The recovery arrived in FY 2081/82 with net profit up 170% to Rs 95.33 crore and ROE back to 22.83%, and continued in FY 2082/83 with net profit of Rs 120.63 crore, up 26.5%, and ROE of 23.13%.

The shape of the latest year is what matters for the growth the price needs. Net profit rose 26.5% but EPS rose only 5.4%, and book value per share rose 4.1% to Rs 141.43 while total equity rose 24.9% to Rs 5.22 arba and total assets 26.2% to Rs 5.77 arba. The equity base is expanding faster than the per-share figures, and the return on equity has now printed 22.83% and 23.13% in consecutive years — a plateau well below the 37.12% of FY 2078/79.

That is the tension the price sits on. The reverse calculation needs a growth rate near the discount rate, on a return on equity around 23%. The record shows a business that can produce those returns, but has done so at this level for two years and off a base growing faster than per-share book.

The assumption set

Every input, stated plainly. The cost of equity is 10%, 12% or 14% — desk scenario inputs, not market data. The return on equity is held either at the latest 23.13% or the five-year median 22.83%. Growth is solved as a perpetual rate, below the cost of equity in every scenario. The price is Rs 1,309 at the 16 October 2026 close, with book value of Rs 141.43 from the FY 2082/83 Q4 filing.

The scenarios: at a 10% cost of equity the price implies 8.41% growth, or 8.45% on the median ROE; at 12%, 10.65% or 10.69%; at 14%, 12.89% or 12.93%. In all three, a steady growth rate below the cost of equity does reach this price — no scenario requires the arithmetic to fail. What the price cannot absorb is a lower return on equity. With no growth at all, it needs an ROE of 92.6% at a 10% cost of equity, 111.12% at 12% and 129.64% at 14%.

The sensitivity is lopsided. Lift the cost of equity one point above 12% and the implied growth rises to 11.77%; lift the return on equity one point and it eases to 10.53%. The discount rate moves the implication far more than the return input, and in the opposite direction — so the assumption that does the work here is the cost of equity, not the operating performance.

Where the implication breaks

Against the sector, 40 times earnings sits below the 48.7 median across 17 companies, with a median price-to-book of 4.95 and a median return on equity of 5.04%. HDL's 9.26x book is far above that median, and the argument for it is the return: 23.13% against 5.04%. Among the named peers, only Unilever Nepal carries a higher multiple on book at 9.02x, and only Unilever Nepal a higher return at 30.92%, on a 29.2x P/E. Sarbottam Cement is 4.05x book on 10.61% ROE and 38.2x earnings; Shivam 3.62x on 7.43% and 48.7x; Bottlers Nepal 3.99x on 12.31% and 32.4x; Reliance Spinning 5.27x on 4.17% and 126.2x; Palpa Cement 4.63x on 0.83% and 559.4x. The pairing of multiple and return, not the multiple alone, is what the price is paying for.

The implication breaks if the return on equity does not hold near 23%. A slide toward the FY 2080/81 path of 10.56% would leave the growth requirement out of reach at every one of the three discount rates, and the no-growth requirement of 111.12% at a 12% cost of equity shows how little slack there is. It breaks from the other side if the cost of equity the market settles at is nearer 14% than 12%: the same price then implies 12.89% growth, a rate that has to persist for the arithmetic to close. The next filing is the test — the ROE path first, the rate environment second. Watch too whether per-share book value keeps lagging the growth in the equity base, and whether buy-initiated flow holds above the 38.8% median of the last ten sessions.